Skip to content

Videotherapy in patients with apraxia – a single-blind randomised controlled cross-over pilot study

Videotherapy in patients with apraxia – a single-blind randomised controlled cross-over pilot study - Videotherapy for Apraxia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027441
Enrollment
12
Registered
2022-06-03
Start date
2022-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

apraxia

Interventions

Group 1: Videotherapy additional to standard therapy Group 2: standard therapy

Sponsors

Inselspital Bern
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: First ischemic or hemorrhagic stroke. Apraxia Screening of TULIA (AST) score <9 pts (score <5 for those with aphasia). 18 years of age or older German speaking (person giving consent must be German speaking)

Exclusion criteria

Exclusion criteria: acquired brain injury other than ischemic or hemorrhagic stroke Foreign language (person giving consent must be german speaking) younger than 18 years cortical blindness

Design outcomes

Primary

MeasureTime frame
Primary outcome (documentation after each intervention, evaluation at the end of the study period). Intensity of additional videotherapy in the rehabilitation setting - Is the intensity of 5x videotherapy sessions within two weeks, in addition to standard therapies, feasible for the subjects? Subjects' attendance or absence at each session will be documented. - Videotherapy is feasible if subjects bring 100% attendance. Videotherapy is not feasible if subjects do not attend all five interventions. Reasons for non-attendance will be documented by the therapist(s). Feasibility of videotherapy in a rehabilitation setting - Are subjects present for 15 minutes and watch the entire video? The length of time subjects are present from each session is documented. - Videotherapy is feasible if subjects are present for 5x15 minutes and participate fully in the sessions. Reasons for discontinuation are documented by the therapist.

Secondary

MeasureTime frame
Secondary outcome (measurements will be taken on study day 1, 22 and 36). - Activity performance (PRPP) - Tool use (DILA-S Familiar Tools & Pantomime Tool Use). - Gesture imitation (DILA-S: Pantomime of meaningful gestures) - Clinical skills (Bartel Index)

Countries

Switzerland

Contacts

Public ContactMagdalena Eichenberger

Universitätsklinik für NeurologieInselspital

magdalena.eichenberger@insel.ch+41 31 632 31 79

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026